Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
0 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to TherapeuticsMD, Inc.’s names, not what it holds today.
Patents granted
0
by type: not read, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
99
4 of them in 2025
Names they are printed under
2
its own name, a subsidiary
By yearGrantedApplications published
'11'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name2 counted
TherapeuticsMD, Inc. its own name
named as the applicant on its applications, in US
98 publishedvitaMedMD, LLC a subsidiary
US, as the owner printed on each patent
1 published
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Dec 25, 2025 | 2025/0387408 | VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS | Pharmaceuticals | TherapeuticsMD, Inc. |
| Dec 25, 2025 | 2025/0387339 | VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS | Pharmaceuticals | TherapeuticsMD, Inc. |
| Nov 27, 2025 | 2025/0360079 | VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS | Pharmaceuticals | TherapeuticsMD, Inc. |
| Oct 23, 2025 | 2025/0325561 | Natural Combination Hormone Replacement Formulations and Therapies | Pharmaceuticals | TherapeuticsMD, Inc. |
| Oct 31, 2024 | 2024/0358839 | PROGESTERONE FORMULATIONS HAVING A DESIRABLE PK PROFILE | Pharmaceuticals | TherapeuticsMD, Inc. |
| Oct 24, 2024 | 2024/0350514 | VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS | Pharmaceuticals | TherapeuticsMD, Inc. |
| Apr 11, 2024 | 2024/0115584 | NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES | Pharmaceuticals | TherapeuticsMD, Inc. |
| Sep 28, 2023 | 2023/0302015 | NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES | Pharmaceuticals | TherapeuticsMD, Inc. |
| Sep 7, 2023 | 2023/0277555 | STEROID HORMONE PHARMACEUTICAL FORMULATIONS | Pharmaceuticals | TherapeuticsMD, Inc. |
| Jul 13, 2023 | 2023/0218636 | Natural Combination Hormone Replacement Formulations and Therapies | Pharmaceuticals | TherapeuticsMD, Inc. |
What it applied for, 2024 to 2025: Pharmaceuticals 7.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.